A Comparison Between Bladder Dissection Before and After Uterine Incision During Cesarean Section for Placenta Accreta Spectrum: A Randomized Controlled Study
Launched by AIN SHAMS UNIVERSITY · Apr 26, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the best way to manage bladder dissection during cesarean sections for women with placenta accreta, a condition where the placenta attaches too deeply into the uterine wall. The trial aims to compare whether it's safer to perform bladder dissection before or after making the uterine incision during the surgery. This is important because placenta accreta can lead to serious complications for both mothers and babies, especially during surgery.
Women who may be eligible to participate in this trial are those who have had at least two previous cesarean sections, have a body mass index (BMI) of 35 or less, are at least 32 weeks pregnant with a viable baby, and have any degree of placenta previa (where the placenta covers the cervix). Participants will need to be willing to provide informed consent and must not have a history of bladder injuries or certain medical conditions. The trial is not yet recruiting, but it represents an important step in improving surgical techniques and outcomes for women facing this challenging condition.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Women with BMI at or under 35kg/m2
- • Women with history of at least previous two caesarean section
- • Gestational age more than 32 weeks with viable fetus.
- • Women with any degree of placenta previa.
- • Women with placenta falling in the PAS.
- • Willing and able to provide informed consent.
- Exclusion Criteria:
- • o History of urinary bladder injury.
- • History of urinary or renal disorders
- • Women with coagulation disorders or on anticoagulation therapy.
- • Patients who are hemodynamically unstable before skin incision
About Ain Shams University
Ain Shams University, established in Cairo, Egypt, is a prestigious higher education institution renowned for its commitment to academic excellence and research innovation. As a clinical trial sponsor, the university leverages its extensive resources and expertise in various medical and scientific disciplines to advance healthcare through rigorous research initiatives. With a focus on ethical practices and adherence to regulatory standards, Ain Shams University aims to contribute to the development of new therapies and improve patient outcomes, fostering collaboration among researchers, healthcare professionals, and industry partners in the pursuit of medical advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
khaled saed, professor
Study Director
direcror
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported